Inventor · disambiguated record
Feng Li
Also filed as: LI FENG · LI FENG-QIAO
24 granted patents·21 pending applications·70 citations·filing 2008–2023
93Inventor score
Files withARIAD PHARMA INC19BAYLOR COLLEGE MEDICINE3FLATLEY DISCOVERY LAB LLC2SCIWIND BIOSCIENCES CO LTD2HEFEI INDUSTRIAL PHARMACEUTICAL INST CO LTD1
Top patents by PatentIndex Score
45 records- 0194US9273077B2Phosphorus derivatives as kinase inhibitorsARIAD PHARMA INC·Filed 2013·Granted Mar 1, 2016·13 cites·51 claims
- 0293US9012462B2Phosphorous derivatives as kinase inhibitorsWANG YIHAN·Filed 2009·Granted Apr 21, 2015·28 cites·72 claims
- 0392US10227342B2Heteroaryl compounds for kinase inhibitionARIAD PHARMA INC·Filed 2015·Granted Mar 12, 2019·7 cites·14 claims
- 0491US9796712B2Heteroaryl compounds for kinase inhibitionARIAD PHARMA INC·Filed 2017·Granted Oct 24, 2017·6 cites·15 claims
- 0585US9024028B2Methods and compositions for the synthesis of multimerizing agentsLI FENG·Filed 2012·Granted May 5, 2015·3 cites·9 claims
- 0684US9834521B2Choline kinase inhibitorsARIAD PHARMA INC·Filed 2014·Granted Dec 5, 2017·4 cites·1 claims
- 0778US11612640B2Acylated GLP-1 derivativeSCIWIND BIOSCIENCES CO LTD·Filed 2019·Granted Mar 28, 2023·1 cites·14 claims
- 0877US11001580B2Aminothiazole compounds as c-Kit inhibitorsARIAD PHARMA INC·Filed 2017·Granted May 11, 2021·1 cites·14 claims
- 0977US2024208960A1Aminothiazole compounds as c-kit inhibitorsARIAD PHARMA INC·Filed 2023·Application pending·0 cites
- 1076US11117883B2Benzimidazole compounds as c-Kit inhibitorsARIAD PHARMA INC·Filed 2017·Granted Sep 14, 2021·1 cites·7 claims
- 1175US11958850B2Heteroaryl compounds for kinase inhibitionTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Apr 16, 2024·0 cites·22 claims
- 1275US8912330B2Azaindole derivatives as kinase inhibitorsQI JIWEI·Filed 2009·Granted Dec 16, 2014·4 cites·28 claims
- 1375US8629242B2Methods of inhibiting calcineurin with ApoE analogsVITEK MICHAEL P·Filed 2008·Granted Jan 14, 2014·2 cites·35 claims
- 1473US2020317705A1Phosphorous derivatives as kinase inhibitorsARIAD PHARMA INC·Filed 2019·Application pending·0 cites
- 1571US12508300B2Acylated GLP-1 derivativeSCIWIND BIOSCIENCES CO LTD·Filed 2023·Granted Dec 30, 2025·0 cites·21 claims
- 1671US11753404B2Aminothiazole compounds as c-Kit inhibitorsARIAD PHARMA INC·Filed 2021·Granted Sep 12, 2023·0 cites·4 claims
- 1765US2019218212A1Heteroaryl compounds for kinase inhibitionARIAD PHARMA INC·Filed 2019·Application pending·0 cites
- 1864US2022064144A1Benzimidazole compounds as c-kit inhibitorsARIAD PHARMA INC·Filed 2021·Application pending·0 cites
- 1964US2020048288A1Phosphorous derivatives as kinase inhibitorsARIAD PHARMA INC·Filed 2019·Application pending·0 cites
- 2063US9573934B2Methods and compositions for the synthesis of multimerizing agentsARIAD PHARMA INC·Filed 2015·Granted Feb 21, 2017·0 cites·20 claims
- 2160US2022402925A1Compounds and methods for the treatment of cystic fibrosisFLATLEY DISCOVERY LAB LLC·Filed 2022·Application pending·0 cites
- 2259US2017218000A1Phosphorous derivatives as kinase inhibitorsARIAD PHARMA INC·Filed 2017·Application pending·0 cites
- 2355US2023055237A1Compounds and methods for the treatment of cystic fibrosisFLATLEY DISCOVERY LAB LLC·Filed 2021·Application pending·0 cites
- 2454US2024026457A1Application of variations in notch family genes in predicting sensitivity to immune checkpoint inhibitor therapy in patients with solid tumorsSHANGHAI ORIGIMED CO LTD·Filed 2021·Application pending·0 cites
- 2553US10772888B2Solid pharmaceutical compositions containing an integrase inhibitorMERCK SHARP & DOHME·Filed 2017·Granted Sep 15, 2020·0 cites·16 claims
- 2653US2024041882A1Mini-tablet dosage form of a viral terminase inhibitor and uses thereofMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 2752US8350033B24-((3, 5, 6-trimethylpyrazine-2-yl) methoxyl) benzoic acid and its derivativesLI JIAMING·Filed 2008·Granted Jan 8, 2013·0 cites·11 claims
- 2852US2016376297A1Phosphorous Derivatives as Kinase InhibitorsARIAD PHARMA INC·Filed 2016·Application pending·0 cites
- 2952US2015225436A1Phosphorous derivatives as kinase inhibitorsARIAD PHARMA INC·Filed 2015·Application pending·0 cites
- 3051US2025304550A1Bromodomain and extra-terminal (bet) subfamily bromodomain 1 (bd1) selective inhibitors and methods using sameBAYLOR COLLEGE MEDICINE·Filed 2023·Application pending·0 cites
- 3149US2022194951A1Dihydropyrimidine compound and application thereof as drugSUNSHINE LAKE PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 3249US2024158355A1Bet subfamily inhibitors and methods using sameBAYLOR COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 3347US2023192606A1Direct thrombin inhibitors and methods of use thereofBAYLOR COLLEGE MEDICINE·Filed 2021·Application pending·0 cites
- 3446US11602534B2Pyrimidine derivative kinase inhibitorsHEFEI INST PHYSICAL SCI CAS·Filed 2017·Granted Mar 14, 2023·0 cites·8 claims
- 3546US11168081B2Alkaloid derivative having angiogenesis inhibitory effect, and pharmaceutical composition containing sameSEOUL NAT UNIV R&DB FOUNDATION·Filed 2018·Granted Nov 9, 2021·0 cites·10 claims
- 3646US2024374609A1Nitrosamine impurity, varenicline pharmaceutical composition capable of reducing generation of nitrosamine impurities and preparation and use thereofVIWIT PHARMACEUTICALCO LTD·Filed 2021·Application pending·0 cites
- 3742US11021507B2Myricetin derivative and preparing method thereof, and application of same for treating colitis, preventing and treating colitis tumorigenesis, and treating colorectal cancerMARINE BIOMEDICAL RES INST QINGDAO CO LTD·Filed 2017·Granted Jun 1, 2021·0 cites·14 claims
- 3842US9649311B2Solid pharmaceutical compositions containing an integrase inhibitorMAHJOUR MAJID·Filed 2010·Granted May 16, 2017·0 cites·46 claims
- 3942US2022235057A1Cyclic formyl and cyclic ketone compounds, preparation method therefor, and pharmaceutical useNANJING UNIVERSITY OF TECHNOLOGY·Filed 2020·Application pending·0 cites
- 4042US2013225528A1Phosphorus Derivatives as Kinase InhibitorsARIAD PHARMA INC·Filed 2013·Application pending·0 cites
- 4142US2013225527A1Phosphorus Derivatives as Kinase InhibitorsARIAD PHARMA INC·Filed 2013·Application pending·0 cites
- 4239US12221448B2Selective PI3Kδ inhibitor and use thereofTARAPEUTICS SCIENCE INC·Filed 2018·Granted Feb 11, 2025·0 cites·13 claims
- 4338US11161860B2Compound having effects of inhibiting phosphodiesterase 4, preparation method thereof and pharmaceutical use thereofHEFEI INDUSTRIAL PHARMACEUTICAL INST CO LTD·Filed 2018·Granted Nov 2, 2021·0 cites·7 claims
- 4433US2017166598A1Heteroaryl compounds for kinase inhibitionARIAD PHARMA INC·Filed 2015·Application pending·0 cites
- 4529US9604974B2Compounds as modulator of JAK-STAT pathway, methods and applications thereofUNIV OF MYSORE·Filed 2016·Granted Mar 28, 2017·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Feng Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →